DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-3.39%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.78B
AUM Growth
+$2.78B
(+6.6%)
Cap. Flow
+$268M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
39.18%
Holding
111
New
16
Increased
25
Reduced
19
Closed
12
Top Buys
| 1 |
Viatris
VTRS
|
$81.2M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$42.1M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$38.4M |
| 4 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$37.1M |
| 5 |
STAAR Surgical
STAA
|
$25.8M |
Top Sells
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$90.8M |
| 2 |
Centene
CNC
|
$19.1M |
| 3 |
Glaukos
GKOS
|
$17.9M |
| 4 |
Axogen
AXGN
|
$17.3M |
| 5 |
Ascendis Pharma
ASND
|
$17M |
Sector Composition
| 1 | Healthcare | 67.78% |
| 2 | Financials | 0.96% |
| 3 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $155M | 5.59% | 6,462,634 | – | – |
|
|
2
Viatris
VTRS
$12.3B
| $142M | 5.11% | 7,464,327 +4,264,538 | +133% | +$81.2M |
|
|
ORTX
3
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $125M | 4.48% | 8,923,600 +900,000 | +11% | +$12.6M |
|
4
Q32 Bio
QTTB
$20.9M
| $113M | 4.05% | 5,760,368 +533,333 | +10% | +$10.4M |
|
|
AERI
5
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $89.6M | 3.22% | 3,032,987 +1,424,202 | +89% | +$42.1M |
|
|
XENT
6
DELISTED
Intersect ENT, Inc
XENT
| $70.8M | 2.54% | 3,109,004 +1,103,040 | +55% | +$25.1M |
|
|
IMMU
7
DELISTED
Immunomedics Inc
IMMU
| $69.1M | 2.48% | 4,985,383 +1,190,600 | +31% | +$16.5M |
|
|
XLRN
8
DELISTED
Acceleron Pharma Inc.
XLRN
| $53.6M | 1.93% | 1,305,174 +50,000 | +4% | +$2.05M |
|
9
Brookdale Senior Living
BKD
$1.83B
| $52M | 1.87% | 7,207,239 +2,045,884 | +40% | +$14.8M |
|
|
RARX
10
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $51.5M | 1.85% | 1,713,000 +211,000 | +14% | +$6.34M |
|
|
MYOK
11
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $50M | 1.8% | 997,000 | – | – |
|
12
Sarepta Therapeutics
SRPT
$1.78B
| $47M | 1.69% | 309,025 -76,975 | -20% | -$11.7M |
|
|
DPLO
13
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $42.9M | 1.54% | 7,036,670 -12,627 | -0.2% | -$76.9K |
|
14
argenx
ARGX
$43.6B
| $39.8M | 1.43% | 281,000 -112,750 | -29% | -$16M |
|
15
Vericel Corp
VCEL
$1.83B
| $39.1M | 1.4% | 2,069,601 +380,601 | +23% | +$7.19M |
|
|
MNK
16
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $38.4M | 1.38% | +4,178,219 | New | +$38.4M |
|
|
17
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $37.1M | 1.33% | +1,678,022 | New | +$37.1M |
|
|
BPMC
18
DELISTED
Blueprint Medicines
BPMC
| $36.9M | 1.33% | 391,254 -115,611 | -23% | -$10.9M |
|
19
Fate Therapeutics
FATE
$120M
| $34.6M | 1.24% | 1,702,897 | – | – |
|
20
Alector
ALEC
$238M
| $33.2M | 1.19% | 1,746,923 -210,000 | -11% | -$3.99M |
|
21
Select Medical
SEM
$1.61B
| $32.4M | 1.16% | 2,043,527 | – | – |
|
22
AnaptysBio
ANAB
$569M
| $30.5M | 1.1% | 540,529 -202,910 | -27% | -$11.4M |
|
23
Editas Medicine
EDIT
$231M
| $28.7M | 1.03% | 1,158,841 | – | – |
|
|
SIEN
24
DELISTED
Sientra, Inc.
SIEN
| $28.7M | 1.03% | 4,652,306 +1,921,674 | +70% | +$11.8M |
|
25
Natera
NTRA
$23.1B
| $27.7M | 0.99% | 1,002,834 -320,000 | -24% | -$8.83M |
|